威高骨科
(688161)
| 流通市值：81.32亿 | | | 总市值：81.32亿 |
| 流通股本：4.00亿 | | | 总股本：4.00亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 970,468,347.02 | 704,424,329.89 | 296,330,838.73 | 1,522,794,046.97 |
| 营业收入 | 970,468,347.02 | 704,424,329.89 | 296,330,838.73 | 1,522,794,046.97 |
| 二、营业总成本 | 773,411,998.15 | 553,854,159.55 | 253,047,152.6 | 1,208,242,886.13 |
| 营业成本 | 352,588,847.18 | 256,593,141.79 | 117,115,903.52 | 534,831,637.27 |
| 税金及附加 | 12,331,169.87 | 9,019,026.07 | 3,869,748.98 | 22,919,684.18 |
| 销售费用 | 236,367,359.24 | 171,637,113.11 | 80,750,419.66 | 422,917,315.58 |
| 管理费用 | 88,775,041.8 | 61,017,722.85 | 26,446,489.88 | 124,834,344.99 |
| 研发费用 | 81,924,875.69 | 54,751,639.17 | 25,069,791.47 | 112,298,962.56 |
| 财务费用 | 1,424,704.37 | 835,516.56 | -205,200.91 | -9,559,058.45 |
| 其中:利息费用 | 263,052.99 | 285,736.19 | 133,793.45 | 975,388.37 |
| 其中:利息收入 | 4,041,211.03 | 3,472,982.4 | 1,958,497.89 | 15,236,419.91 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 139,586.31 | 261,739.73 | -270,473.98 | 1,247,084.46 |
| 加:投资收益 | 23,532,268.49 | 13,933,353.27 | 6,198,148.98 | 30,924,370.7 |
| 资产处置收益 | -47,671.12 | -10,100.76 | 16,407.27 | 146,849.42 |
| 资产减值损失(新) | -8,413,684.75 | -8,413,688.49 | -3.74 | -32,272,551.75 |
| 信用减值损失(新) | -4,451,019.69 | -3,636,415.36 | -944,160.29 | -7,285,091.61 |
| 其他收益 | 7,720,359.69 | 6,743,339 | 4,268,109.58 | 16,105,271.23 |
| 四、营业利润 | 215,536,187.8 | 159,448,397.73 | 52,551,713.95 | 323,417,093.29 |
| 加:营业外收入 | 265,706.79 | 259,343.27 | 56,017.47 | 1,644,299.51 |
| 减:营业外支出 | 5,451,835 | 26,276.25 | 2,375.28 | 995,650.4 |
| 五、利润总额 | 210,350,059.59 | 159,681,464.75 | 52,605,356.14 | 324,065,742.4 |
| 减:所得税费用 | 33,442,383.93 | 27,922,850.78 | 9,291,818.44 | 50,261,004.73 |
| 六、净利润 | 176,907,675.66 | 131,758,613.97 | 43,313,537.7 | 273,804,737.67 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 176,907,675.66 | 131,758,613.97 | 43,313,537.7 | 273,804,737.67 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 177,650,297.39 | 132,231,492.32 | 44,229,577.44 | 268,643,514.62 |
| 少数股东损益 | -742,621.73 | -472,878.35 | -916,039.74 | 5,161,223.05 |
| 扣除非经常损益后的净利润 | 172,830,241.68 | 125,915,962.69 | 40,867,094.09 | 254,674,965.84 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.45 | 0.33 | 0.11 | 0.68 |
| (二)稀释每股收益 | 0.45 | 0.33 | 0.11 | 0.67 |
| 九、综合收益总额 | 176,907,675.66 | 131,758,613.97 | 43,313,537.7 | 273,804,737.67 |
| 归属于母公司股东的综合收益总额 | 177,650,297.39 | 132,231,492.32 | 44,229,577.44 | 268,643,514.62 |
| 归属于少数股东的综合收益总额 | -742,621.73 | -472,878.35 | -916,039.74 | 5,161,223.05 |
| 公告日期 | 2026-10-31 | 2026-08-26 | 2026-04-30 | 2026-03-28 |
| 审计意见(境内) | | | | 标准无保留意见 |